Signal from the log
Biotia
9 M$ · Series A · United States · Diagnostics
Biotia vend un test d'urine qui lit par séquençage tout l'ADN microbien de l'échantillon, puis l'interprète par IA, pour trouver la cause des infections urinaires récidivantes que la culture classique ne voit pas. L'extension de série A ne nomme pas de chef de file.
Verified
Announced on , logged by the watch of 1 October 2026.
- Operation
- Funding round
- Announced amount
- 9 M$
- Stage
- Series A
- Country
- United States
- Sector
- Diagnostics
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
With Convergent Ventures , DigitalDx Ventures , Cloquet Capital Partners , Continuum Health Ventures , I-Lab Angels , EGB Capital , Leawood Venture Capital , Red Bear Angels , Red Bear Ventures
Provenance
Source prnewswire
Logged on 1 October 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.